Vensana Capital—an independent, medtech-focused venture capital investment firm supported by Versant Ventures—has launched with a $225 million fund and ambitions to support new breakthroughs in medical devices, diagnostics and data science.
{iframe}https://www.fiercebiotech.com/medtech/versant-backs-new-medtech-focused-vensana-capital-fund-launching-225m{/iframe}